179 related articles for article (PubMed ID: 29487694)
1. Ependymomas overexpress chemoresistance and DNA repair-related proteins.
Ferguson SD; Zhou S; Xiu J; Hashimoto Y; Sanai N; Kim L; Kesari S; de Groot J; Spetzler D; Heimberger AB
Oncotarget; 2018 Jan; 9(8):7822-7831. PubMed ID: 29487694
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma.
Friedrich C; von Bueren AO; Kolevatova L; Bernreuther C; Grob T; Sepulveda-Falla D; van den Boom L; Westphal M; Simon R; Glatzel M
Childs Nerv Syst; 2016 Feb; 32(2):281-90. PubMed ID: 26686534
[TBL] [Abstract][Full Text] [Related]
3. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
[TBL] [Abstract][Full Text] [Related]
4. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy in addition to surgical resection may not improve overall survival in WHO grade II spinal ependymomas.
Brown DA; Goyal A; Takami H; Graffeo CS; Mahajan A; Krauss WE; Bydon M
Clin Neurol Neurosurg; 2020 Feb; 189():105632. PubMed ID: 31862631
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of histopathological ependymoma variants.
Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.
Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M;
Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291
[TBL] [Abstract][Full Text] [Related]
8. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
[TBL] [Abstract][Full Text] [Related]
9. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.
Rousseau A; Idbaih A; Ducray F; Crinière E; Fèvre-Montange M; Jouvet A; Delattre JY
J Neurooncol; 2010 May; 97(3):353-64. PubMed ID: 19865800
[TBL] [Abstract][Full Text] [Related]
10. Expression of ERCC1, RRM1, TUBB3 in correlation with apoptosis repressor ARC, DNA mismatch repair proteins and p53 in liver metastasis of colorectal cancer.
Tóth C; Sükösd F; Valicsek E; Herpel E; Schirmacher P; Renner M; Mader C; Tiszlavicz L; Kriegsmann J
Int J Mol Med; 2017 Nov; 40(5):1457-1465. PubMed ID: 28949378
[TBL] [Abstract][Full Text] [Related]
11. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
12. Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy.
Gleeson EM; Feldman R; Mapow BL; Mackovick LT; Ward KM; Morano WF; Rubin RR; Bowne WB
Am J Clin Oncol; 2018 Aug; 41(8):777-783. PubMed ID: 28263231
[TBL] [Abstract][Full Text] [Related]
13. Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy.
Jiang H; Wang H; Wang S; Pei Z; Fu Z; Fang C; Wang J; Lu Q; Wang E; Li J
Mol Med Rep; 2015 May; 11(5):3523-32. PubMed ID: 25573098
[TBL] [Abstract][Full Text] [Related]
14. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of immunoexpression of the chemoresistance-related proteins in ependymomas: an analysis of 76 cases.
Korshunov A; Sycheva R; Timirgaz V; Golanov A
J Neurooncol; 1999; 45(3):219-27. PubMed ID: 10845392
[TBL] [Abstract][Full Text] [Related]
16. Low-grade ependymoma with late metastasis: autopsy case study and literature review.
Alshaya W; Mehta V; Wilson BA; Chafe S; Aronyk KE; Lu JQ
Childs Nerv Syst; 2015 Sep; 31(9):1565-72. PubMed ID: 25957762
[TBL] [Abstract][Full Text] [Related]
17. Profiles of brain metastases: Prioritization of therapeutic targets.
Ferguson SD; Zheng S; Xiu J; Zhou S; Khasraw M; Brastianos PK; Kesari S; Hu J; Rudnick J; Salacz ME; Piccioni D; Huang S; Davies MA; Glitza IC; Heymach JV; Zhang J; Ibrahim NK; DeGroot JF; McCarty J; O'Brien BJ; Sawaya R; Verhaak RGW; Reddy SK; Priebe W; Gatalica Z; Spetzler D; Heimberger AB
Int J Cancer; 2018 Dec; 143(11):3019-3026. PubMed ID: 29923182
[TBL] [Abstract][Full Text] [Related]
18. Survival outcomes and prognostic factors of patients with intramedullary Grade II ependymomas after surgical treatments.
Sun XY; Kong C; Lu SB; Sun SY; Guo MC; Ding JZ
J Clin Neurosci; 2018 Nov; 57():136-142. PubMed ID: 30146401
[TBL] [Abstract][Full Text] [Related]
19. Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design.
Everson RG; Hashimoto Y; Freeman JL; Hodges TR; Huse J; Zhou S; Xiu J; Spetzler D; Sanai N; Kim L; Kesari S; Brenner A; De Monte F; Heimberger A; Raza SM
J Neurooncol; 2018 Sep; 139(2):469-478. PubMed ID: 29846894
[TBL] [Abstract][Full Text] [Related]
20. Prognosis by tumor location in adults with spinal ependymomas.
Oh MC; Kim JM; Kaur G; Safaee M; Sun MZ; Singh A; Aranda D; Molinaro AM; Parsa AT
J Neurosurg Spine; 2013 Mar; 18(3):226-35. PubMed ID: 23311515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]